Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Amstutz

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Immunology Letters|August 3, 2010
DARPins against a functional IgE epitopeMichael J Baumann, Alexander Eggel, Patrick Amstutz, et al.
Journal of the American Chemical Society|August 9, 2002
In vitro selection for catalytic activity with ribosome displayPatrick Amstutz, Joelle N Pelletier, Armin Guggisberg, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Designed ankyrin repeat proteins as anti-idiotypic-binding moleculesMonique Vogel, Elsbeth Keller-Gautschi, Michael J Baumann, et al.
The Journal of Biological Chemistry|April 27, 2005
Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteinsPatrick Amstutz, H Kaspar Binz, Petra Parizek, et al.
Nature Biotechnology|April 21, 2004
High-affinity binders selected from designed ankyrin repeat protein librariesH Kaspar Binz, Patrick Amstutz, Andreas Kohl, et al.
Structure (London, England : 1993)|August 9, 2005
Allosteric inhibition of aminoglycoside phosphotransferase by a designed ankyrin repeat proteinAndreas Kohl, Patrick Amstutz, Petra Parizek, et al.
Structure (London, England : 1993)|May 16, 2007
Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanismAndreas Schweizer, Heidi Roschitzki-Voser, Patrick Amstutz, et al.
Plos Pathogens|July 26, 2008
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristicsAndreas Schweizer, Peter Rusert, Livia Berlinger, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 9, 2008
Structure of wild-type Plk-1 kinase domain in complex with a selective DARPinTiago M Bandeiras, Roman Christian Hillig, Pedro M Matias, et al.
Nature Biotechnology|July 21, 2022
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variantsSylvia Rothenberger, Daniel L Hurdiss, Marcel Walser, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Immunology Letters|August 3, 2010
DARPins against a functional IgE epitopeMichael J Baumann, Alexander Eggel, Patrick Amstutz, et al.
Journal of the American Chemical Society|August 9, 2002
In vitro selection for catalytic activity with ribosome displayPatrick Amstutz, Joelle N Pelletier, Armin Guggisberg, et al.
Annals of the New York Academy of Sciences|September 6, 2007
Designed ankyrin repeat proteins as anti-idiotypic-binding moleculesMonique Vogel, Elsbeth Keller-Gautschi, Michael J Baumann, et al.
The Journal of Biological Chemistry|April 27, 2005
Intracellular kinase inhibitors selected from combinatorial libraries of designed ankyrin repeat proteinsPatrick Amstutz, H Kaspar Binz, Petra Parizek, et al.
Nature Biotechnology|April 21, 2004
High-affinity binders selected from designed ankyrin repeat protein librariesH Kaspar Binz, Patrick Amstutz, Andreas Kohl, et al.
Structure (London, England : 1993)|August 9, 2005
Allosteric inhibition of aminoglycoside phosphotransferase by a designed ankyrin repeat proteinAndreas Kohl, Patrick Amstutz, Petra Parizek, et al.
Structure (London, England : 1993)|May 16, 2007
Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanismAndreas Schweizer, Heidi Roschitzki-Voser, Patrick Amstutz, et al.
Plos Pathogens|July 26, 2008
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristicsAndreas Schweizer, Peter Rusert, Livia Berlinger, et al.
Acta Crystallographica. Section D, Biological Crystallography|April 9, 2008
Structure of wild-type Plk-1 kinase domain in complex with a selective DARPinTiago M Bandeiras, Roman Christian Hillig, Pedro M Matias, et al.
Nature Biotechnology|July 21, 2022
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variantsSylvia Rothenberger, Daniel L Hurdiss, Marcel Walser, et al.
Pageof 2